Investigation Overview
An investigation on behalf of investors of Myomo Inc (NYSEAMERICAN:MYO) shares over potential securities laws violations by Myomo Inc and certain of its directors and officers in connection with certain financial statements was announced.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Myomo Inc (NYSEAMERICAN:MYO) concerning whether a series of statements by Myomo Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Cambridge, MA based Myomo, Inc. is a United States-based medical device company specializing in myoelectric orthotics for people with neurological disorders. Myomo Inc went public on June 12, 2017 and shares of Myomo Inc (NYSEAMERICAN:MYO) reached $23.20 per share on June 2019, 2017. In late November 2017 shares of Myomo Inc (NYSEAMERICAN:MYO) declined to $2.07 per share.